Uso de agente esclerosante como coadjuvante ao tratamento cirúrgico do hemangioma cavernoso em língua: relato de caso.

Abstract

The hemangioma is, according to the World Health Organization (WHO), a benign vascular neoplasm, characterized by abnormal proliferation of blood vessels. It can be congenital or traumatic etiology prevalent in head and neck, and can affect the skin, mucous membranes and bone. Clinically it presents as a macula, blister or nodule whose color varies from deep red to purple according to its location and depth in the tissue. This study aims to report a case of cavernous hemangioma in a tongue treated with therapeutic sclerosis with weekly injections of monoethanolamine oleate (Ethamolin), as coadjuvants to surgical treatment. A 12-year-old male patient attended from Crato-CE in Center for Dental Specialties (CEO) with a histopathological report of Cavernous Hemangioma in the tongue. The patient's mother reported that the child has had the lesion since birth, with an increase in size and color change throughout the patient's life. Clinically, the lesion was swollen, with several diffuse sessile papillary lesions, asymptomatic and with a color ranging from deep red to purple. Through a precise diagnosis and adequate therapeutic management, the case has been undergoing preservation for 1 year and 7 months, without signs of relapse, improving its psychosocial behavior, phonation and swallowing, and a satisfactory aesthetic result.